SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018789
Filing Date
2023-05-08
Accepted
2023-05-08 16:06:26
Documents
65
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20230331.htm   iXBRL 10-Q 2548955
2 EX-10.1 vir-ex10_1.htm EX-10 252413
3 EX-10.2 vir-ex10_2.htm EX-10 196952
4 EX-10.3 vir-ex10_3.htm EX-10 60195
5 EX-10.4 vir-ex10_4.htm EX-10 135030
6 EX-31.1 vir-ex31_1.htm EX-31 22091
7 EX-31.2 vir-ex31_2.htm EX-31 22056
8 EX-32.1 vir-ex32_1.htm EX-32 14552
  Complete submission text file 0000950170-23-018789.txt   9567406

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20230331.xsd EX-101.SCH 96452
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20230331_pre.xml EX-101.PRE 483239
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20230331_def.xml EX-101.DEF 350318
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20230331_lab.xml EX-101.LAB 675756
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20230331_cal.xml EX-101.CAL 65675
59 EXTRACTED XBRL INSTANCE DOCUMENT vir-20230331_htm.xml XML 1223990
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 23897737
SIC: 2836 Biological Products, (No Diagnostic Substances)